Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANTERN: Lanreotide Autogel vs PR in Acromegaly
NCT02493517Phase 3Completed
- Sponsor
- Ipsen
- Start
- Oct 2014
- Primary completion
- Nov 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lanreotide in acromegaly, sponsored by Ipsen. Started Oct 2014; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT02493517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493517.